VA Data Shows Sharp Rise in Traumatic Brain Injury Cases Among Veterans

  • VA data shows a significant increase in TBI cases among veterans from 2001 to 2025, with higher screening, reporting, and diagnosis rates.
  • Documented cases may underrepresent the true scale due to unreported injuries and potential misdiagnoses.
  • No FDA-approved treatments exist for TBI, despite promising research in diagnostic and treatment solutions.
  • DAV and Invisible Wounds Foundation urge Congress to increase funding for veteran-centered TBI research.

The rise in documented TBI cases among veterans reflects both increased awareness and potential underreporting. This underscores a critical gap in diagnostic tools and treatment options, necessitating greater investment in research to address the long-term health impacts on military and veteran communities. The call for congressional action highlights the broader challenge of aligning healthcare policy with the evolving needs of those affected by modern warfare.

Research Funding
Whether Congress will allocate additional funds for TBI research, given the urgency highlighted by DAV and Invisible Wounds Foundation.
Diagnostic Advances
The pace at which precision diagnostic tools for TBI are developed, particularly for blast exposure and long-term effects.
Treatment Breakthroughs
How soon FDA-approved treatments for TBI could emerge, given the current lack of targeted therapies.